Neurestrol: AG/E, a joint venture of Apollo and Endocon, filed an IND for a Phase I trial in 12 normal post-menopausal women

Apollo Genetics Inc., Cambridge, Mass. Endocon Inc., South Walpole, Mass. Product: Neurestrol, estrogen-based agent in an implant to deliver the drug over six months Indication: Protect against neuro...